Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known which combination chemotherapy regimen is more
effective following surgery for breast cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of combination chemotherapy
consisting of cyclophosphamide, methotrexate, and fluorouracil with or without epirubicin in
treating women who have early stage breast cancer.